| Wenny Tan, OD | |
|
1505 Annapolis Mall, Annapolis, MD 21401-3090 | |
| (410) 573-2095 | |
| Not Available |
| Full Name | Wenny Tan |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 1505 Annapolis Mall, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114309051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | TA2469 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wenny Tan, OD 8 Charles Plz Apt 405, Baltimore, MD 21201-4202 Ph: () - | Wenny Tan, OD 1505 Annapolis Mall, Annapolis, MD 21401-3090 Ph: (410) 573-2095 |
News Archive
A tsunami of chronic health conditions as a result of the SARS-CoV-2 pandemic, especially cardiometabolic disease, may produce an enormous wave of death and disability that demands immediate, comprehensive strategies.
Researchers have identified a type of genetic aberration to be the cause of certain neurodevelopmental disorders and congenital diseases, such as autism and congenital heart disease, which are undetectable by conventional genetic testing.
Emerging Healthcare Solutions, Inc.: Last week, the US Food and Drug Administration gave their highly-anticipated approval for the first clinical trial using human embryonic stem cells (hESCs), which are the type of cells that can develop into all tissues of the body. Geron Corporation of Menlo Park, California, received the green light from the US FDA to use cells derived from hESCs to treat people with acute spinal cord injuries. Ten people will receive injections into the injury site of hESC-derived oligodendrocyte progenitor cells, which stimulate the growth of new and severed nerves and recoat damaged nerves with myelin. The hope is that the injections will help people recover function lost through injury, as seen in rodent studies in 2005.
Robert Rieveley, President of Biotech Holdings has announced that installation of pharmaceutic processing equipment required for Sucanon production is currently being completed. "Sucanon production is scheduled to begin within the week; our first production run is for 1.2 million Sucanon tablets, sufficient for 20,000 one-month Sucanon treatment packages.
Patients infected with a particular subtype of HIV, the virus that causes AIDS, are more likely to develop dementia than patients with other subtypes, a study led by Johns Hopkins researchers shows. The finding, reported in the September Clinical Infectious Diseases, is the first to demonstrate that the specific type of HIV has any effect on cognitive impairment, one of the most common complications of uncontrolled HIV infection.
› Verified 5 days ago
Dr. Ryan Shaun Sullivan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2321 Forest Dr, Annapolis, MD 21401 Phone: 410-266-3369 | |
Jonathan Jacesko, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. David A Byman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-3617 | |
Dr. Elizabeth C Mcmunn, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-4378 | |
Dr. Jay Thompson Rorick, MD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 888 Bestgate Road, Suite 102, Annapolis, MD 21401 Phone: 410-571-7325 Fax: 410-571-7301 | |
Anchor Eyecare Annapolis Optometrist Medicare: Not Enrolled in Medicare Practice Location: 321 Kinkaid Rd, Building 329, Annapolis, MD 21402 Phone: 410-757-8169 Fax: 410-349-0079 |